Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
boston blog main
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
acorda therapeutics
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
ampyra
amunix
anirvan ghosh
apokyn
apomorphine
astrazeneca
biogen
biotech
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
dalfampridine
deals
deerfield management
detroit blog main
detroit top stories
duopa
durvalumab
editas medicine
europe blog main
europe top stories
What
help
2
×
acorda
acquisitions
announced
approved
bio
ceo
collabs
cope
covid
daniel
deal
disease
drug
episodes
fda
friday
gets
gilead
gilead’s
introduce
ipo
late
looms
meant
medications
medicines
month
new
nod
o’day
parkinson’s
patients
plans
rival
roundup
sciences
stop
transformative
treatment
Language
unset
Current search:
abbvie
×
help
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
